Replies to post #36338 on Regen BioPharma Inc (RGBP)

[Fireindahole101]

Check the facts, this patent could be worth a LOT of money:

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in an efficacious manner while appearing not to induce any form of toxicity. In a series of experiments, Regen collaborators extracted immune system cells from mice called 'dendritic cells'. These cells where treated with cannabidiol, which caused suppression of their ability to activate cancer killing immune T cells. Surprisingly, in the presence of NR2F6 inhibition, the cannabidiol actually increased ability to activate T cells. The Company currently possesses small molecule inhibitors of NR2F6, as well as various genetic means such as inducers of RNA Interference, to block expression of NR2F6.

CEO David Koos also went on to say:

the Company aims to develop a new class of checkpoint inhibitors that concurrently block tumor growth while enhancing the immune system."

From the 8-7-19 PR. Whole new ball game here, and proven effective.




$$$RGBP$$$

[joe botts]

Ok